$1.25 Billion is the total value of GREAT POINT PARTNERS LLC's 36 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 61.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CNST | Buy | CONSTELLATION PHARMCETICLS I | $104,574,000 | +68.3% | 3,480,000 | +76.0% | 8.36% | +28.7% |
| IOVA | Buy | IOVANCE BIOTHERAPEUTICS INC | $102,251,000 | +43.1% | 3,724,976 | +56.0% | 8.17% | +9.5% |
| ZYME | Buy | ZYMEWORKS INC | $92,869,000 | +12.6% | 2,574,688 | +10.8% | 7.42% | -13.8% |
| ACAD | Sell | ACADIA PHARMACEUTICALS INC | $87,488,000 | +3.8% | 1,804,993 | -9.6% | 6.99% | -20.6% |
| SAGE | Buy | SAGE THERAPEUTICS INC | $87,416,000 | +66.8% | 2,102,368 | +15.2% | 6.99% | +27.6% |
| ARNA | Buy | ARENA PHARMACEUTICALS INC | $81,986,000 | +403.8% | 1,302,399 | +236.1% | 6.55% | +285.5% |
| UTHR | Buy | UNITED THERAPEUTICS CORP DEL | $75,020,000 | +42.2% | 620,000 | +11.5% | 6.00% | +8.8% |
| TGTX | Buy | TG THERAPEUTICS INC | $64,689,000 | +157.2% | 3,320,808 | +29.9% | 5.17% | +96.8% |
| BHVN | Buy | BIOHAVEN PHARMACTL HLDG CO L | $61,478,000 | +210.5% | 840,900 | +44.5% | 4.91% | +137.5% |
| GWPH | GW PHARMACEUTICALS PLCads | $55,224,000 | +40.1% | 450,000 | 0.0% | 4.41% | +7.2% | |
| AKBA | New | AKEBIA THERAPEUTICS INC | $47,667,000 | – | 3,510,073 | +100.0% | 3.81% | – |
| MGNX | New | MACROGENICS INC | $41,880,000 | – | 1,500,000 | +100.0% | 3.35% | – |
| CYTK | Buy | CYTOKINETICS INC | $35,841,000 | +357.7% | 1,520,635 | +129.0% | 2.86% | +250.2% |
| GBT | New | GLOBAL BLOOD THERAPEUTICS IN | $34,229,000 | – | 542,200 | +100.0% | 2.74% | – |
| GERN | New | GERON CORP | $33,568,000 | – | 15,398,079 | +100.0% | 2.68% | – |
| VCEL | New | VERICEL CORP | $22,252,000 | – | 1,610,154 | +100.0% | 1.78% | – |
| PRTA | PROTHENA CORP PLC | $21,787,000 | -2.2% | 2,082,841 | 0.0% | 1.74% | -25.2% | |
| NXTC | Sell | NEXTCURE INC | $21,433,000 | -56.0% | 999,666 | -23.9% | 1.71% | -66.3% |
| ABEO | ABEONA THERAPEUTICS INC | $21,026,000 | +38.8% | 7,213,012 | 0.0% | 1.68% | +6.2% | |
| GKOS | New | GLAUKOS CORP | $19,210,000 | – | 500,000 | +100.0% | 1.54% | – |
| MTEM | Buy | MOLECULAR TEMPLATES INC | $18,553,000 | +69.2% | 1,345,397 | +63.1% | 1.48% | +29.4% |
| PTCT | Sell | PTC THERAPEUTICS INC | $16,744,000 | -78.7% | 330,000 | -81.3% | 1.34% | -83.7% |
| AXNX | Sell | AXONICS MODULATION TECHNOLOG | $16,133,000 | +16.9% | 459,503 | -15.4% | 1.29% | -10.5% |
| SGMO | Buy | SANGAMO THERAPEUTICS INC | $14,156,000 | +250.8% | 1,579,891 | +149.4% | 1.13% | +168.2% |
| CTMX | Buy | CYTOMX THERAPEUTICS INC | $12,067,000 | +1025.7% | 1,448,604 | +936.8% | 0.96% | +761.6% |
| CALA | New | CALITHERA BIOSCIENCES INC | $11,942,000 | – | 2,261,700 | +100.0% | 0.96% | – |
| LQDA | LIQUIDIA TECHNOLOGIES INC | $10,760,000 | +78.8% | 1,277,955 | 0.0% | 0.86% | +36.7% | |
| ARVN | Buy | ARVINAS INCcall | $6,825,000 | +63.6% | 203,500 | +96.6% | 0.55% | +25.2% |
| DNLI | New | DENALI THERAPEUTICS INC | $6,770,000 | – | 280,000 | +100.0% | 0.54% | – |
| VRAY | VIEWRAY INC | $6,213,000 | -10.4% | 2,773,811 | 0.0% | 0.50% | -31.4% | |
| OYST | New | OYSTER PT PHARMA INC | $6,199,000 | – | 214,631 | +100.0% | 0.50% | – |
| XLRN | Sell | ACCELERON PHARMA INC | $5,531,000 | -88.5% | 58,056 | -89.2% | 0.44% | -91.2% |
| KDMN | New | KADMON HLDGS INC | $3,459,000 | – | 675,679 | +100.0% | 0.28% | – |
| MLND | Sell | MILLENDO THERAPEUTICS INC | $2,571,000 | -71.8% | 1,460,697 | -15.6% | 0.21% | -78.4% |
| PBYI | New | PUMA BIOTECHNOLOGY INC | $965,000 | – | 92,502 | +100.0% | 0.08% | – |
| NLTX | Sell | NEOLEUKIN THERAPEUTICS INC | $233,000 | -49.2% | 14,065 | -65.1% | 0.02% | -60.4% |
| KURA | Exit | KURA ONCOLOGY INC | $0 | – | -179,700 | -100.0% | -0.19% | – |
| MNLO | Exit | MENLO THERAPEUTICS INC | $0 | – | -1,652,013 | -100.0% | -0.46% | – |
| ARVN | Exit | ARVINAS INC | $0 | – | -118,330 | -100.0% | -0.50% | – |
| AXSM | Exit | AXSOME THERAPEUTICS INC | $0 | – | -100,100 | -100.0% | -0.62% | – |
| TGTX | Exit | TG THERAPEUTICS INCcall | $0 | – | -1,000,000 | -100.0% | -1.03% | – |
| CCXI | Exit | CHEMOCENTRYX INC | $0 | – | -357,379 | -100.0% | -1.50% | – |
| MYOK | Exit | MYOKARDIA INC | $0 | – | -364,163 | -100.0% | -1.78% | – |
| MYOK | Exit | MYOKARDIA INCcall | $0 | – | -500,000 | -100.0% | -2.45% | – |
| MNTA | Exit | MOMENTA PHARMACEUTICALS INC | $0 | – | -979,400 | -100.0% | -2.78% | – |
| ABMD | Exit | ABIOMED INC | $0 | – | -216,144 | -100.0% | -3.28% | – |
| BHVN | Exit | BIOHAVEN PHARMACTL HLDG CO Lcall | $0 | – | -1,000,000 | -100.0% | -3.56% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| STREAMLINE HEALTH SOLUTNS, INC CMN | 25 | Q3 2019 | 2.5% |
| IOVANCE BIOTHERAPEUTICS, INC. CMN | 16 | Q1 2021 | 14.3% |
| ZOGENIX INC CMN | 16 | Q4 2019 | 8.8% |
| PTC THERAPEUTICS, INC. CMN | 16 | Q3 2023 | 9.9% |
| EXELIXIS, INC | 16 | Q1 2022 | 7.5% |
| SAGE THERAPEUTICS, INC CMN | 15 | Q3 2021 | 10.8% |
| CYTOKINETICS INC | 15 | Q3 2023 | 5.8% |
| ACADIA PHARMACEUTICALS, INC. | 14 | Q1 2021 | 8.8% |
| ACCELERON PHARMA INC CMN | 14 | Q2 2020 | 8.2% |
| CONNECTURE INC | 13 | Q4 2017 | 25.1% |
View GREAT POINT PARTNERS LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| 89bio, Inc. | February 14, 2023 | 700,000 | 1.4% |
| KalVista Pharmaceuticals, Inc. | February 14, 2023 | 1,055,801 | 3.1% |
| Avalo Therapeutics, Inc. | February 13, 2023 | 974,639 | 7.1% |
| InflaRx N.V.Sold out | February 14, 2022 | 0 | 0.0% |
| ABEONA THERAPEUTICS INC.Sold out | February 16, 2021 | 0 | 0.0% |
| CONSTELLATION PHARMACEUTICALS INC | February 16, 2021 | 1,024,800 | 2.2% |
| GERON CORP | February 16, 2021 | 12,754,228 | 4.0% |
| Millendo Therapeutics, Inc. | February 16, 2021 | 270,000 | 1.4% |
| NextCure, Inc.Sold out | February 16, 2021 | 0 | 0.0% |
| PROTHENA CORP PUBLIC LTD CO | February 16, 2021 | 977,647 | 2.4% |
View GREAT POINT PARTNERS LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-04-08 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View GREAT POINT PARTNERS LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.